Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-23T10:52:25.024Z Has data issue: false hasContentIssue false
  • English
  • Français

Patient Outcomes Following Ketamine Administration for Acute Agitation with a Decreased Dosing Protocol in the Prehospital Setting

Published online by Cambridge University Press:  08 March 2021

Cassidy Cunningham Open the ORCID record for Cassidy Cunningham [Opens in a new window] ,
Karen Gross ,
John P. Broach  and
Laurel O’Connor Open the ORCID record for Laurel O’Connor [Opens in a new window]
Cassidy Cunningham*
Affiliation:
University of New England College of Osteopathic Medicine, Biddeford, MaineUSA
Karen Gross
Affiliation:
Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, MassachusettsUSA
John P. Broach
Affiliation:
Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, MassachusettsUSA
Laurel O’Connor
Affiliation:
Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, MassachusettsUSA
*
Correspondence: Cassidy Cunningham, MS University of New England College of Osteopathic Medicine 11 Hills Beach Road, Biddeford, Maine 04005USA E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Agitated behaviors are frequently encountered in the prehospital setting and require emergent treatment to prevent harm to patients and prehospital personnel. Chemical sedation with ketamine works faster than traditional pharmacologic agents, though it has a higher incidence of adverse events, including intubation. Outcomes following varying initial doses of prehospital intramuscular (IM) ketamine use have been incompletely described.

Objective:

To determine whether using a lower dose IM ketamine protocol for agitation is associated with more favorable outcomes.

Methods:

This study was a pre-/post-intervention retrospective chart review of prehospital care reports (PCRs). Adult patients who received chemical sedation in the form of IM ketamine for agitated behaviors were included. Patients were divided into two cohorts based on the standard IM ketamine dose of 4mg/kg and the lower IM dose of 3mg/kg with the option for an additional 1mg/kg if required. Primary outcomes included intubation and hospital admission. Secondary outcomes included emergency department (ED) length of stay, additional chemical or physical restraints, assaults on prehospital or ED employees, and documented adverse events.

Results:

The standard dose cohort consisted of 211 patients. The lower dose cohort consisted of 81 patients, 17 of whom received supplemental ketamine administration. Demographics did not significantly differ between the cohorts (mean age 35.14 versus 35.65 years; P = .484; and 67.8% versus 65.4% male; P = .89). Lower dose subjects were administered a lower ketamine dose (mean 3.24mg/kg) compared to the standard dose cohort (mean 3.51mg/kg). There was no statistically significant difference between the cohorts in intubation rate (14.2% versus 18.5%; P = .455), ED length of stay (14.31 versus 14.88 hours; P = .118), need for additional restraint and sedation (P = .787), or admission rate (26.1% versus 25.9%; P = .677). In the lower dose cohort, 41.2% (7/17) of patients who received supplemental ketamine doses were intubated, a higher rate than the patients in this cohort who did not receive supplemental ketamine (8/64, 12.5%; P <.01).

Conclusion:

Access to effective, fast-acting chemical sedation is paramount for prehospital providers. No significant outcomes differences existed when a lower dose IM ketamine protocol was implemented for prehospital chemical sedation. Patients who received a second dose of ketamine had a significant increase in intubation rate. A lower dose protocol may be considered for an agitation protocol to limit the amount of medication administered to a population of high-risk patients.

Keywords

acute agitationketamineparamedicsafetysedation
Type
Original Research
Information
Prehospital and Disaster Medicine , Volume 36 , Issue 3 , June 2021 , pp. 276 - 282
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the World Association for Disaster and Emergency Medicine

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Pajonk, FG, Schmitt, P, Biedler, A, et al. Psychiatric emergencies in prehospital emergency medical systems: a prospective comparison of two urban settings. Gen Hosp Psychiatry. 2008;30(4):360–366.CrossRefGoogle ScholarPubMed
Gill, JR. The syndrome of excited delirium. Forensic Sci Med Pathol. 2014;10(2):223–228.CrossRefGoogle ScholarPubMed
Abdon-Beckman, D. An awkward position: restraints and sudden death. JEMS. 1997;22(3):88.Google ScholarPubMed
Bak, M, Weltens, I, Bervoets, C, et al. The pharmacological management of agitated and aggressive behavior: a systematic review and meta-analysis. Eur Psychiatry. 2019;57:78–100.CrossRefGoogle ScholarPubMed
Wolff, K, Winstock, AR. Ketamine: from medicine to misuse. CNS Drugs. 2006;20(3):199–218.CrossRefGoogle ScholarPubMed
Green, SM, Roback, MG, Kennedy, RM, Krauss, B. Clinical practice guideline for emergency department ketamine dissociative sedation: 2011 update. Ann Emerg Med. 2011;57(5):449–461.CrossRefGoogle ScholarPubMed
Cole, JB, Moore, JC, Nystrom, PC, et al. A prospective study of ketamine versus haloperidol for severe prehospital agitation. Clin Toxicol (Phila). 2016;54(7):556–562.CrossRefGoogle ScholarPubMed
O’Connor, L, Rebesco, M, Robinson, C, et al. Outcomes of prehospital chemical sedation with ketamine versus haloperidol and benzodiazepine or physical restraint only. Prehosp Emerg Care. 2019;23(2):201–209.CrossRefGoogle ScholarPubMed
Linder, LM, Ross, CA, Weant, KA. Ketamine for the acute management of excited delirium and agitation in the prehospital setting. Pharmacotherapy. 2018;38(1):139–151.CrossRefGoogle ScholarPubMed
Mankowitz, SL, Regenberg, P, Kaldan, J, Cole, JB. Ketamine for rapid sedation of agitated patients in the prehospital and emergency department settings: a systematic review and proportional meta-analysis. J Emerg Med. 2018;55(5):670–681.CrossRefGoogle ScholarPubMed
Burnett, AM, Peterson, BK, Stellpflug, SJ, et al. The association between ketamine given for prehospital chemical restraint with intubation and hospital admission. Am J Emerg Med. 2015;33(1):76–79.CrossRefGoogle ScholarPubMed
Olives, TD, Nystrom, PC, Cole, JB, Dodd, KW, Ho, JD. Intubation of profoundly agitated patients treated with prehospital ketamine. Prehosp Disaster Med. 2016;31(6):593–602.CrossRefGoogle ScholarPubMed
Scheppke, KA, Braghiroli, J, Shalaby, M, Chait, R. Prehospital use of IM ketamine for sedation of violent and agitated patients. Western J Emerg Med. 2014;15(7):736–741.CrossRefGoogle Scholar
Massachusetts Department of Public Health. “2.4 Behavioral Emergencies Adult & Pediatric.” In: Emergency Medical Services Prehospital Statewide Treatment Protocols (V2019.2). Boston, Massachusetts USA: Massachusetts Department of Public Health Office of Emergency Medical Services; 2019.Google Scholar
Li, M, Martinelli, AN, Oliver, WD, Wilkerson, RG. Evaluation of ketamine for excited delirium syndrome in the adult emergency department. J Emerg Med. 2019;S0736-4679(19):30802–30809.Google Scholar
Gao, M, Rejaei, D, Liu, H. Ketamine use in current clinical practice. Acta Pharmacol Sin. 2016;37(7):865–872.CrossRefGoogle ScholarPubMed
Tobias, JD, Leder, M. Procedural sedation: a review of sedative agents, monitoring, and management of complications. Saudi J Anaesth. 2011;5(4):395–410.CrossRefGoogle ScholarPubMed
Song, JW, Shim, JK, Song, Y, Yang, SY, Park, SJ, Kwak, YL. Effect of ketamine as an adjunct to intravenous patient-controlled analgesia, in patients at high risk of postoperative nausea and vomiting undergoing lumbar spinal surgery. Br J Anaesth. 2013;111(4):630–635.CrossRefGoogle ScholarPubMed
Loo, CK, Gálvez, V, O’Keefe, E, et al. Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression. Acta Psychiatr Scand. 2016;134(1):48–56.CrossRefGoogle ScholarPubMed
Grange, JT, Corbett, SW. Violence against emergency medical services personnel. Prehosp Emerg Care. 2002;6(2):186–190.CrossRefGoogle ScholarPubMed
Maguire, BJ, Smith, S. Injuries and fatalities among emergency medical technicians and paramedics in the United States. Prehosp Disaster Med. 2013;28(4):376–382.CrossRefGoogle ScholarPubMed
Supplementary material: File

Cunningham et al. supplementary material

Tables S1-S3

Download Cunningham et al. supplementary material(File)
File 20.5 KB